| 注册
首页|期刊导航|医学信息|前列地尔注射液联合厄贝沙坦治疗糖尿病肾病的临床观察

前列地尔注射液联合厄贝沙坦治疗糖尿病肾病的临床观察

李惠芳

医学信息Issue(6):133-133,1.
医学信息Issue(6):133-133,1.

前列地尔注射液联合厄贝沙坦治疗糖尿病肾病的临床观察

Clinical Observation of Alprostadil Injection Combined with Irbesartan Treatment of Diabetic Nephropathy

李惠芳1

作者信息

  • 1. 商丘市中心医院,河南 商丘 476000
  • 折叠

摘要

Abstract

Objective compare the curative ef ect of diabetic nephropathy between alprostadil joint irbesartan and lonely irbesartan. Methods:56 cases of diabetic nephropathy patients were randomly divided into treatment group and control group, Treatment group given alprostadil joint irbesartan treatment;Observe two groups before and after treatment serum creatinine, blood urea nitrogen, the change of the 24 h urine trace albumin. Result:Treatment group than the control group after treatment, the serum creatinine, blood urea nitrogen, 24 h urine trace albumin improves obviously, statistical y significant dif erence between the two groups (P<0.05). Conclusion:alprostadil joint irbesartan treatment of diabetic nephropathy have bet er safety and tolerability, can ef ectively reduce the urine protein, is an ef ective method for the treatment of diabetic nephropathy.

关键词

前列地尔/厄贝沙坦/糖尿病肾病/尿蛋白

Key words

Alprostadil/Irbesartan/Diabetic nephropathy/Urine protein

引用本文复制引用

李惠芳..前列地尔注射液联合厄贝沙坦治疗糖尿病肾病的临床观察[J].医学信息,2014,(6):133-133,1.

医学信息

1006-1959

访问量0
|
下载量0
段落导航相关论文